Govt seeks details of Patanjali's COVID-19 remedy claim, halts it from advertising now
New Delhi/IBNS: The Ministry of Ayush on Tuesday asked yoga guru Ramdev’s Patanjali Ayurved Ltd to provide details of the Ayurvedic medicine 'Coronil', which it has developed for the treatment of COVID-19, and to stop publicising or advertising the drug until the claims are duly examined.
Ramdev earlier in the day launched Ayurvedic medicine Coronil which he claimed will help in curing a patient of the infectious disease.
Launch of first and foremost evidence-based ayurvedic medicine for Covid-19@yogrishiramdev @Ach_Balkrishna #Patanjali #आयà¥à¤°à¥à¤µà¥‡à¤¦à¤µà¤¿à¤œà¤¯_कोरोनिल_शà¥à¤µà¤¾à¤¸à¤¾à¤°à¤¿ pic.twitter.com/3hiyUSnZJX
— Patanjali Ayurved (@PypAyurved) June 23, 2020
Taking cognizance of the news from media, the Ministry of Ayush stated that facts of the claim and details of the stated scientific study 'are not known to the Ministry.'
"The concerned Ayurvedic drug manufacturing company has been informed that such advertisements of drugs including Ayurvedic medicines are regulated under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder and the directives issued by the Central Government in the wake of COVID outbreak, " the ministry said in a statement.
The Ministry said that it sought details of the composition of the drug from Patanjali Ayurved based in Haridwar and until the results of the claim are verified, the company has been refrained from advertising the medicine.
"In order to make this Ministry aware of the facts of the aforesaid news and verify the claims, Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results from data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined," the statement said.
"Ministry has also requested concerned State Licensing Authority of Uttrakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19," it added.
Launching the medicine earlier in the day from Haridwar, the company said that clinical control trials of the medicine were carried out adhering to standardized protocols and within the span of 3 to 15 days, all the COVID-19 positive patients transformed into negative ones without observing any mortality, said reports.
According to reports, the medicine was launched after a research conducted jointly by the Patanjali Research Institute, Haridwar and the National Institute of Medical Science, Jaipur.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
